EUR 19.98
(-0.35%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.02 Billion EUR | 9.11% |
2022 | 939.64 Million EUR | -6.11% |
2021 | 1 Billion EUR | 5.83% |
2020 | 945.7 Million EUR | -6.26% |
2019 | 1 Billion EUR | -6.66% |
2018 | 1.08 Billion EUR | 13.34% |
2017 | 953.59 Million EUR | -7.25% |
2016 | 1.02 Billion EUR | 13.92% |
2015 | 902.49 Million EUR | 89.75% |
2014 | 475.63 Million EUR | 3.5% |
2013 | 459.55 Million EUR | -0.31% |
2012 | 460.96 Million EUR | 2.5% |
2011 | 449.71 Million EUR | 6.57% |
2010 | 422.01 Million EUR | 7.02% |
2009 | 394.31 Million EUR | 2.97% |
2008 | 382.95 Million EUR | 7.21% |
2007 | 357.21 Million EUR | 9.4% |
2006 | 326.51 Million EUR | 10.38% |
2005 | 295.81 Million EUR | 15.7% |
2004 | 255.67 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.04 Billion EUR | 0.0% |
2023 Q4 | 1.02 Billion EUR | 0.0% |
2023 FY | 1.02 Billion EUR | 9.11% |
2023 Q2 | 991.22 Million EUR | 0.0% |
2022 Q2 | 1 Billion EUR | 0.0% |
2022 Q4 | 939.64 Million EUR | 0.0% |
2022 FY | 939.64 Million EUR | -6.11% |
2021 FY | 1 Billion EUR | 5.83% |
2021 Q2 | 960.09 Million EUR | 0.0% |
2021 Q4 | 1 Billion EUR | 0.0% |
2020 Q4 | 945.7 Million EUR | 0.0% |
2020 Q2 | 964.83 Million EUR | 0.0% |
2020 FY | 945.7 Million EUR | -6.26% |
2019 Q4 | 1 Billion EUR | 0.0% |
2019 FY | 1 Billion EUR | -6.66% |
2019 Q2 | 1.06 Billion EUR | 0.0% |
2018 Q4 | 1.08 Billion EUR | 0.0% |
2018 FY | 1.08 Billion EUR | 13.34% |
2018 Q2 | 1.03 Billion EUR | 0.0% |
2017 Q2 | 962.03 Million EUR | 0.0% |
2017 FY | 953.59 Million EUR | -7.25% |
2017 Q4 | 953.59 Million EUR | 0.0% |
2016 Q2 | 951.13 Million EUR | 0.0% |
2016 FY | 1.02 Billion EUR | 13.92% |
2016 Q4 | 1.02 Billion EUR | 0.0% |
2015 FY | 902.49 Million EUR | 89.75% |
2015 Q4 | 902.49 Million EUR | 0.0% |
2015 Q2 | 494.05 Million EUR | 0.0% |
2014 Q2 | 469.15 Million EUR | 0.0% |
2014 Q4 | 475.63 Million EUR | 0.0% |
2014 FY | 475.63 Million EUR | 3.5% |
2013 Q4 | 459.55 Million EUR | 0.0% |
2013 Q2 | 467.55 Million EUR | 0.0% |
2013 FY | 459.55 Million EUR | -0.31% |
2012 Q2 | 461.96 Million EUR | 0.0% |
2012 FY | 460.96 Million EUR | 2.5% |
2012 Q4 | 460.96 Million EUR | 0.0% |
2011 Q4 | 449.71 Million EUR | 0.0% |
2011 Q2 | 428.74 Million EUR | 0.0% |
2011 FY | 449.71 Million EUR | 6.57% |
2010 FY | 422.01 Million EUR | 7.02% |
2010 Q2 | 415.91 Million EUR | 0.0% |
2010 Q4 | 422.01 Million EUR | 0.0% |
2009 FY | 394.31 Million EUR | 2.97% |
2009 Q4 | 394.31 Million EUR | 0.0% |
2008 FY | 382.95 Million EUR | 7.21% |
2007 FY | 357.21 Million EUR | 9.4% |
2006 FY | 326.51 Million EUR | 10.38% |
2005 FY | 295.81 Million EUR | 15.7% |
2004 FY | 255.67 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Affluent Medical SA | 56.62 Million EUR | -1710.646% |
Bluelinea Société Anonyme | 13.16 Million EUR | -7687.794% |
Carmat SA | 53.06 Million EUR | -1831.904% |
Diagnostic Medical Systems S.A. | 51.13 Million EUR | -1904.854% |
Euromedis Groupe | 46.25 Million EUR | -2116.336% |
Eurobio Scientific Société anonyme | 315.81 Million EUR | -224.634% |
Ikonisys S.A. | 20.85 Million EUR | -4816.617% |
Implanet S.A. | 10.63 Million EUR | -9538.451% |
Median Technologies SA | 35.81 Million EUR | -2762.845% |
SpineGuard SA | 11.03 Million EUR | -9190.525% |
Theraclion SA | 18.66 Million EUR | -5393.279% |
Euroapi S.A. | 1.61 Billion EUR | 36.415% |